Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Simon

Showing results (61-70 of 79) with videos related to

Pageof 8
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1986
The pathologic and clinical heterogeneity of lymphocyte-depleted Hodgkin's diseaseJ A Kant, S M Hubbard, D L Longo, et al.
Cancer|December 15, 1982
Malignant lymphoma. 1. The histology and staging of 473 patients at the National Cancer InstituteT Anderson, B A Chabner, R C Young, et al.
Cancer|December 15, 1982
Malignant lymphoma. II Prognostic factors and response to treatment of 473 patients at the National Cancer InstituteT Anderson, V T DeVita, R M Simon, et al.
Cancer|April 15, 1981
Natural history of malignant lymphomas with divergent histologies at staging evaluationR I Fisher, R B Jones, V T DeVita, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 26, 1998
Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseasesK G Becker, R M Simon, J E Bailey-Wilson, et al.
Journal of Cellular Biochemistry|October 1, 1996
Oncogene alterations in primary, recurrent, and metastatic human bone tumorsF Pompetti, P Rizzo, R M Simon, et al.
Statistics in Medicine|March 15, 1994
Discrimination techniques applied to the NCI in vitro anti-tumour drug screen: predicting biochemical mechanism of actionA D Koutsoukos, L V Rubinstein, D Faraggi, et al.
Blood|July 1, 1980
Nodular histiocytic lymphoma: an aggressive nodular lymphoma with potential for prolonged disease-free survivalC K Osborne, L Norton, R C Young, et al.
Annals of Internal Medicine|December 1, 1979
Delata-9-tetrahydrocannabinol as an antiemetic in cancer patients receiving high-dose methotrexate. A prospective, randomized evaluationA E Chang, D J Shiling, R C Stillman, et al.
The New England Journal of Medicine|July 8, 1976
Randomized clinical trials. Perspectives on some recent ideasD P Byar, R M Simon, W T Friedewald, et al.
Pageof 8

Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1986
The pathologic and clinical heterogeneity of lymphocyte-depleted Hodgkin's diseaseJ A Kant, S M Hubbard, D L Longo, et al.
Cancer|December 15, 1982
Malignant lymphoma. 1. The histology and staging of 473 patients at the National Cancer InstituteT Anderson, B A Chabner, R C Young, et al.
Cancer|December 15, 1982
Malignant lymphoma. II Prognostic factors and response to treatment of 473 patients at the National Cancer InstituteT Anderson, V T DeVita, R M Simon, et al.
Cancer|April 15, 1981
Natural history of malignant lymphomas with divergent histologies at staging evaluationR I Fisher, R B Jones, V T DeVita, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 26, 1998
Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseasesK G Becker, R M Simon, J E Bailey-Wilson, et al.
Journal of Cellular Biochemistry|October 1, 1996
Oncogene alterations in primary, recurrent, and metastatic human bone tumorsF Pompetti, P Rizzo, R M Simon, et al.
Statistics in Medicine|March 15, 1994
Discrimination techniques applied to the NCI in vitro anti-tumour drug screen: predicting biochemical mechanism of actionA D Koutsoukos, L V Rubinstein, D Faraggi, et al.
Blood|July 1, 1980
Nodular histiocytic lymphoma: an aggressive nodular lymphoma with potential for prolonged disease-free survivalC K Osborne, L Norton, R C Young, et al.
Annals of Internal Medicine|December 1, 1979
Delata-9-tetrahydrocannabinol as an antiemetic in cancer patients receiving high-dose methotrexate. A prospective, randomized evaluationA E Chang, D J Shiling, R C Stillman, et al.
The New England Journal of Medicine|July 8, 1976
Randomized clinical trials. Perspectives on some recent ideasD P Byar, R M Simon, W T Friedewald, et al.
Pageof 8